Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosin

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Alp, Harun ^a   Varol, Sefer ^a   Celik, Muhammet Murat ^b   Altas, Murat ^b   Evliyaoglu, Osman ^a   Tokgoz, Orhan ^a   Tanrverdi, Mehmet Halis ^a   Uzar, Ertugrul ^a  

^a DICLE UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; BETA GLUCAN; CATALASE; GLICLAZIDE; MALONALDEHYDE; OXIDIZING AGENT; STREPTOZOCIN; ANTIDIABETIC AGENT; ANTIOXIDANT; BETA 1,3 GLUCAN; BETA 1,6 GLUCAN; BETA-1,3-D-GLUCAN; BETA-1,6-GLUCAN; NERVE PROTEIN; PON 1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; WISTAR ALBINO GLAXO RAT; ANIMAL; BRAIN; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; ENZYMOLOGY; METABOLISM; NERVE CELL; OXIDATION REDUCTION REACTION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BETA-GLUCANS; CATALASE; CEREBRUM; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; FEMALE; GLICLAZIDE; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; NERVE TISSUE PROTEINS; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; SCIATIC NERVE; STREPTOZOCIN;

EID: 84856405899     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/230342     Document Type: Article

References (46)

1. Perkins B. A., Bril V., Emerging therapies for diabetic neuropathy: a clinical overview Current Diabetes Reviews 2005 1 3 271 280
2. Reijmer Y. D., van den Berg E., de Bresser J., Kessels R. P., Kappelle L. J., Algra A., Biessels G. J., Utrecht Diabetic Encephalopathy Study Group, Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors Diabetes/Metabolism Research and Reviews 2011 27 2 195 202
3. Shanmugam K. R., Mallikarjuna K., Kesireddy N., Sathyavelu Reddy K., Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin- induced diabetic rats Food and Chemical Toxicology 2011 49 4 893 897
4. Arnal E., Miranda M., Barcia J., Bosch-Morell F., Romero F. J., Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex Neuroscience 2010 166 1 271 278
5. Zheng Z., Chen H., Wang H., Ke B., Zheng B., Li Q., Li P., Su L., Gu Q., Xu X., Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor coactivator 1 Diabetes 2010 59 9 2315 2325
6. Giacco F., Brownlee M., Oxidative stress and diabetic complications Circulation Research 2010 107 9 1058 1070
7. Cumaolu A., Ozansoy G., Irat A. M., Ariciolu A., Karasu., Ar N., Effect of long term, non cholesterol lowering dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats European Journal of Pharmacology 2011 654 1 80 85
8. Chen J., Raymond K., Beta-glucans in the treatment of diabetes and associated cardiovascular risks Vascular Health and Risk Management 2008 4 6 1265 1272
9. Chen J., Seviour R., Medicinal importance of fungal -(1→3), (1→6)-glucans Mycological Research 2007 111 6 635 652
10. Babincov M., Bacov Z., Machov E., Kogan G., Antioxidant properties of carboxymethyl glucan: comparative analysis Journal of Medicinal Food 2002 5 2 79 83 (Pubitemid 34831272)
11. Alper G., Irer S., Duman E., Caglayan O., Yilmaz C., Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and DNA damage in a diabetic rat model Endocrine Research 2005 31 3 199 212 (Pubitemid 41769963)
12. Pennathur S., Heinecke J. W., Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy Frontiers in Bioscience 2004 9 565 574 (Pubitemid 39043735)
13. Uzar E., Alp H., Cevik M. U., Frat U., Evliyaoglu O., Tufek A., Altun Y., Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurological Sciences. In press
14. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent The Journal of Biological Chemistry 1951 193 1 265 275
15. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Analytical Biochemistry 1979 95 2 351 358 (Pubitemid 9194347)
16. Aebi H., Catalase in vitro Methods in Enzymology 1984 105 121 126
17. Eckerson H. W., Wyte C. M., La Du B. N., The human serum paraoxonase/arylesterase polymorphism American Journal of Human Genetics 1983 35 6 1126 1138 (Pubitemid 14201166)
18. Erel O., A novel automated method to measure total antioxidant response against potent free radical reactions Clinical Biochemistry 2004 37 2 112 119 (Pubitemid 38077161)
19. Erel O., A new automated colorimetric method for measuring total oxidant status Clinical Biochemistry 2005 38 12 1103 11111 (Pubitemid 41797751)
20. Ozturk E., Balat O, Aclms Y. G., Ozcan C., Pence S., Erel., Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method Journal of Obstetrics and Gynaecology Research 2011 37 4 337 342
21. Aycicek A., Erel O., Kocyigit A., Increased oxidative stress in infants exposed to passive smoking European Journal of Pediatrics 2005 164 12 775 778 (Pubitemid 41609481)
22. Zochodne D. W., Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms Muscle Nerve 2007 36 2 144 166 (Pubitemid 47221852)
23. Ozkul A., Ayhan M., Yenisey C., Akyol A., Guney E., Ergin F. A., The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain Neuroendocrinology Letters 2010 31 2 261 264
24. Hoffman W. H., Siedlak S. L., Wang Y., Castellani R. J., Smith M. A., Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis Brain Research 2011 1369 194 202
25. Saravanan G., Ponmurugan P., Beneficial effect of S-allylcysteine (SAC) on blood glucose and pancreatic antioxidant system in streptozotocin diabetic rats Plant Foods for Human Nutrition 2010 65 4 374 378
26. Cui X. P., Li B. Y., Gao H. Q., Wei N., Wang W. L., Lu M., Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats Journal of Nutritional Science and Vitaminology 2008 54 4 321 328
27. Chen L. L., Yu F., Zeng T. S., Liao Y. F., Li Y. M., Ding H. C., Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes European Journal of Pharmacology 2011 659 2-3 296 301
28. Noda Y., Mori A., Packer L., Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study Research Communications in Molecular Pathology and Pharmacology 1997 96 2 115 124 (Pubitemid 27287764)
29. Delibas N., Kilinc I., Yonden Z., Sutcu R., Gultekin F., Koylu H., NMDA receptor subunits 2A and 2B decrease and lipid peroxidation increase in the hippocampus of streptozotocin-diabetic rats: effects of insulin and gliclazide treatments International Journal of Neuroscience 2004 114 3 391 401 (Pubitemid 38268782)
30. Aslan M., Sabuncu T., Kocyigit A., Celik H., Selek S., Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients Nutrition, Metabolism and Cardiovascular Diseases 2007 17 10 734 740 (Pubitemid 350088438)
31. Nourooz-Zadeh J., Ziegler D., Sohr C., Betteridge J. D., Knight J., Hothersall J., The use of pholasin as a probe for the determination of plasma total antioxidant capacity Clinical Biochemistry 2006 39 1 55 61
32. Saluk-Juszczak J., Krolewska K., Wachowicz B., (1→3)- -D-Glucan inhibits a dual mechanism of peroxynitrite stroke International Journal of Biological Macromolecules 2011 48 3 488 494
33. Senoglu N., Yuzbasioglu M. F., Aral M., Ezberci M., Kurutas E. B., Bulbuloglu E., Ezberci F., Oksuz H., Ciragil P., Protective effects of N-acetylcysteine and -glucan pretreatment on oxidative stress in cecal ligation and puncture model of sepsis Journal of Investigative Surgery 2008 21 5 237 243
34. Panahi S., Ezatagha A., Temelli F., Vasanthan T., Vuksan V., -glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity Journal of the American College of Nutrition 2007 26 6 639 644
35. Jenkins A. L., Jenkins D. J. A., Zdravkovic U., Wrsch P., Vuksan V., Depression of the glycemic index by high levels of -glucan fiber in two functional foods tested in type 2 diabetes European Journal of Clinical Nutrition 2002 56 7 622 628 (Pubitemid 34822901)
36. Berdal M., Appelbom H. I., Eikrem J. H., Lund., Zykova S., Busund L. T., Seljelid R., Jenssen T., Aminated -1,3-D-glucan improves wound healing in diabetic db/db mice Wound Repair and Regeneration 2007 15 6 825 832 (Pubitemid 350135230)
37. Shah V. B., Williams D. L., Keshvara L., -Glucan attenuates TLR2- and TLR4-mediated cytokine production by microglia Neuroscience Letters 2009 458 3 111 115
38. Li L., Renier G., The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells Atherosclerosis 2009 204 1 40 46
39. Del Guerra S., Grupillo M., Masini M., Lupi R., Bugliani M., Torri S., Boggi U., Del Chiaro M., Vistoli F., Mosca F., Del Prato S., Marchetti P., Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose Diabetes/Metabolism Research and Reviews 2007 23 3 234 238 (Pubitemid 46437850)
40. Sliwinska A., Blasiak J., Kasznicki J., Drzewoski J., In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM) Chemico-Biological Interactions 2008 173 3 159 165
41. Onozato M. L., Tojo A., Goto A., Fujita T., Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet Kidney International 2004 65 3 951 960 (Pubitemid 38251071)
42. Zhang C., Peng W., Wang M., Zhu J., Zang Y., Shi W., Zhang J., Qin J., Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice Gene Therapy 2010 17 5 626 633
43. Inoue M., Suehiro T., Nakamura T., Ikeda Y., Kumon Y., Hashimoto K., Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes Metabolism 2000 49 11 1400 1405
44. Jafarnejad A., Bathaie S. Z., Nakhjavani M., Hassan M. Z., Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model Life Sciences 2008 82 5-6 301 307
45. Petraitiene R., Petraitis V., Hope W. W., Mickiene D., Kelaher A. M., Murray H. A., Mya-San C., Hughes J. E., Cotton M. P., Bacher J., Walsh T. J., Cerebrospinal fluid and plasma (1→3)- -D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis Antimicrobial Agents and Chemotherapy 2008 52 11 4121 4129
46. Al-Salami H., Butt G., Tucker I., Mikov M., Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats Pharmacological Reports 2008 60 4 532 541